Looks like ACL is getting active in trying to promote HA-I. Seems to be a very good summary of MCRC and HA-I trial.
http://euroscan.org.uk/technologies/technology/view/2686
"Expected reporting date: Primary completion date reported as mid-2014."
Looks like we would know some time around June/July as that is how I would interpret mid-2014.
- Forums
- ASX - By Stock
- TSN
- ha-irinotecan for metastatic colorectal cancer
ha-irinotecan for metastatic colorectal cancer
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable